AMHERST, N.Y. and WOODLAND HILLS, Calif., Dec. 14, 2007 (PRIME NEWSWIRE) -- HealthSport, Inc. (OTCBB:HSPO), a fully integrated developer, manufacturer and marketer of branded nutritional supplements in a one-of-a-kind edible film strip delivery system, announced today that Hank Durschlag has been appointed interim CEO of the Company as it looks to expand its potential product lines from nutraceutical products to OTC prescription and veterinarian drug markets.
Mr. Durschlag has served on the Company's Board of Directors since September 2006 and is a co-inventor of the Enlyten SportStrips and PediaStrips. These two products were the first to deliver needed electrolytes to its users using the patent-pending oral delivery technology developed by HealthSport's wholly-owned subsidiary, Innozen, Inc. Along with patents related to thin film technology, Mr. Durschlag has co-authored patents in the fields of drug delivery and diabetes.
"The Company has begun to make strides in the marketing and sales of our original home grown products, Enlyten and Fix Hangover Strips, but the Company's real future is its proprietary strip technology. Our proprietary technology is capable of delivering drug actives in a faster, more efficient method than most pills and liquids, and it will become a major emphasis for us to begin developing relationships with pharmaceutical companies like the one we currently have with Shearing Plough to develop all types of prescription and non-prescription drugs through our patent pending technology," stated Hank Durschlag, CEO.
About HealthSport, Inc.
HealthSport, Inc. (http://healthsportinc.com) Is a fully integrated developer, manufacturer and marketer of unique and proprietary branded and private label edible film strip nutritional supplements and over-the-counter drugs. The Company owns three subsidiaries -- Enlyten, Inc., InnoZen, Inc. and Cooley Nutraceuticals, Inc. Enlyten was created to market and distribute HealthSport's products. Innozen, Inc. (http://www.innozen.com) is the preeminent formulator, developer and manufacturer of edible film strips that deliver drug actives through buccal (between the cheek and gum) absorption. Innozen's proprietary edible film strip delivery technology is superior to any other competitive edible film strips currently on the market. Innozen has five patents pending and has developed numerous trade secrets which it incorporates in the development and manufacturing process of edible film strips. The Company's current products are sold through its wholly-owned subsidiary, Enlyten, Inc. Further information concerning the benefits of the Company's edible thin film strips can be found at http://enlytenstrips.com.
Forward-Looking Statements in this news release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain risks, and uncertainties and actual results could differ from those discussed. This material is information only, and is not an offer or solicitation to buy or sell the securities.